Show simple item record

dc.contributor.authorCharles, Marvin
dc.date.accessioned2020-10-21T10:04:17Z
dc.date.available2020-10-21T10:04:17Z
dc.date.issued2020
dc.identifier.citationCharles, M. (2020). SA part of a charge to develop a vaccine for Covid-19. Cape Argus. https://www.iol.co.za/capeargus/news/sa-part-of-a-charge-to-develop-a-vaccine-for-covid-19-46431493en_US
dc.identifier.urihttps://www.iol.co.za/capeargus/news/sa-part-of-a-charge-to-develop-a-vaccine-for-covid-19-46431493
dc.identifier.urihttp://hdl.handle.net/10566/5294
dc.description.abstractCape Town - With infections of the coronavirus surpassing the 1.3million mark and deaths at 76507 worldwide, the rush to find a cure is increasing, with South Africa playing its part. Globally, more than 35 companies and academic institutions are racing to create a vaccine, at least four of which already have candidates to test on animals.en_US
dc.language.isoenen_US
dc.publisherIndependent onlineen_US
dc.subjectSouth Africaen_US
dc.subjectCovid-19en_US
dc.subjectDevelopment of vaccineen_US
dc.subjectWorld Health Organisation (WHO)en_US
dc.titleSA part of a charge to develop a vaccine for Covid-19en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record